Millicent Lin

Millicent Lin has a diverse range of work experience in the scientific research field. Millicent currently works as a Scientist at Landmark Bio since 2023. Prior to that, they were a Graduate Research Assistant and PhD Candidate at Northwestern University from September 2018 to March 2023. During this time, they developed immunostimulatory spherical nucleic acids and a metal-phenolic nanopattern library, as well as discovered the regulation of cellular uptakes through nanoscopic ligand arrangements. From September 2017 to August 2018, Millicent worked as a Graduate Research Assistant at Harvard Medical School. Millicent also had experience as a Research Intern at Massachusetts genre in 2017 and as an Associate Scientist at Next Generation Genomics from 2015 to 2016. Additionally, Millicent worked as a Research Associate at the University of California, Los Angeles from November 2012 to April 2015. In this role, they led a team in the development of a platform for isolating circulating tumor cells, conducted multiple studies on the Wnt signaling pathway, and demonstrated the feasibility of detecting circulating tumor cells in cases of gestational choriocarcinoma.

Millicent Lin has a robust education history in the field of biomedical and medical engineering. Millicent holds a Doctor of Philosophy (PhD) degree from Northwestern University, with a specialization in Biomedical/Medical Engineering. Prior to that, they pursued a Master of Science (MS) degree in Bioengineering and Biomedical Engineering from Tufts University. Their undergraduate education was completed at the University of California, Santa Cruz, where they obtained a Bachelor of Science (BS) degree in Molecular Biology.

In addition to their academic achievements, Millicent is also a certified GEM Associate Fellow. Millicent received this certification in 2018 from The National GEM Consortium, although the specific month of attainment is not provided.